• No results found

Growth patterns and body composition in former extremely low birth weight (ELBW) neonates until adulthood: a systematic review

N/A
N/A
Protected

Academic year: 2021

Share "Growth patterns and body composition in former extremely low birth weight (ELBW) neonates until adulthood: a systematic review"

Copied!
15
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

ORIGINAL ARTICLE

Growth patterns and body composition in former extremely low birth

weight (ELBW) neonates until adulthood: a systematic review

Caroline Van de Pol1 &Karel Allegaert2,3

Received: 25 June 2019 / Revised: 10 December 2019 / Accepted: 12 December 2019 # Springer-Verlag GmbH Germany, part of Springer Nature 2020

Abstract

Preterm infants are obviously born lighter and shorter, with smaller head circumferences than normal birth weight term born neonates. They also have a different body composition. Compromised growth is associated with adverse health outcomes. Both growth retardation and accelerated growth are suggested to cause metabolic, cardiovascular, and renal complications. Reviews regarding growth and body composition in preterm infants often do not differen-tiate between birth weight and gestational age. The purpose of this systematic review is to assemble growth data, specific in extremely low birth weight children. Different databases were searched for studies regarding growth and body composition in former extremely low birth weight infants until adulthood. We compared height, weight, head circumference, body mass index, fat mass, lean mass, fat distribution, and body water to matched normal birth weight controls and the World Health Organization growth charts. Studies consistently reported that former extreme-ly low birth weight neonates experience a period of accelerated postnatal growth, but they achieve lower anthropo-metric parameters than normal birth weight children. There is no consensus about differences in body composition and how to measure this.

Conclusion: Although extremely low birth weight infants exhibit a period of catch-up growth, their growth remains retarded later in life. Further research is needed to investigate body composition and the associated risk of cardiovascular diseases or metabolic syndrome.

What is Known:

• Extremely low birth weight infants have lower anthropometric parameters and a different body composition at birth and term-corrected age than normal birth weight infants.

• Former extremely low birth weight infants also have a higher risk on adverse cardiovascular health outcomes in later life. What is New:

• After hospital discharge, extremely low birth weight neonates remain smaller and probably also lighter, with smaller head circumferences at each corrected age throughout childhood and adolescence when compared to normal birth weight infants or the World Health Organization growth charts. It is not clear whether extremely low birth weight infants reach a lower or similar body mass index score as normal birth weight infants.

• There is a lack of (long-term) information on body composition in extremely low birth weight infants.

Keywords Anthropometry . Body composition . Extremely low birth weight . Fat distribution . Growth . Total body fat Abbreviations

AGA Appropriate for gestational age BMI Body mass index

BW Birth weight CA Corrected age

CPEG Canadian Pediatric Endocrine Group ELBW Extremely low birth weight

FM Fat mass

FMI Fat mass index %FM Percentage fat mass GA Gestational age HC Head circumference * Karel Allegaert

karel.allegaert@uzleuven.be Caroline Van de Pol

caroline.vandepol@gmail.com 1

KU Leuven, Leuven, Belgium 2

Department of Development and Regeneration, and Department of Pharmaceutical and Pharmacological Sciences Organ Systems, KU Leuven, Leuven, Belgium

3 Department of Clinical Pharmacy, Erasmus MC, Erasmus MC,

Rotterdam, The Netherlands https://doi.org/10.1007/s00431-019-03552-z

(2)

LM Lean mass LMI Lean mass index %LM Percentage lean mass NBW Normal birth weight TBF Total body fat

%TBF Percentage total body fat TBW Total body water

%TBW Percentage total body water SGA Small for gestational age TCA Term corrected age WHO World Health Organization SSE Sum of squared estimate of errors RMSE Root mean square error

Introduction

Growth patterns and body development are relevant in pre-term infants, likely most relevant in extremely low birth weight (ELBW, i.e., <1 kg) infants. Infants born preterm are lighter and shorter, with a smaller head circumference (HC) than their term born normal birth weight (NBW) peers, at birth as well as when they reach term-corrected age (TCA) and throughout childhood [1,2]. When preterm infants are classi-fied by weight, as ELBW infants, they are often small for their gestational age (SGA) [3]. This makes them even more sus-ceptible to effects of perinatal growth retardation [4].

The perinatal growth retardation is followed by a period of catch-up growth, which usually starts in early infancy and can continue into early adolescence [5].

Preterm infants do not only have aberrant growth measure-ments but they also have a different body composition com-pared to term born neonates. Because the third trimester is a period of rapid adipose tissue deposition, they exhibit a fat distribution at TCA different than that of term born neonates. Preterm infants have a lower fat mass (FM) and an even more decreased lean mass (LM) at TCA, resulting in a greater per-centage total body fat (%TBF) than term born infants [2].

Low birth weight (LBW) infants, and even more ELBW infants are more susceptible to coronary heart diseases, neo-natal acute kidney injury, chronic kidney disease, type 2 dia-betes, stroke, and hypertension [6–8].

Although the effects of (early) infancy weight gain on later body composition and health outcomes are not clear, associa-tions with an aberrant fat distribution, cardiovascular diseases, and an obesity-associated exacerbation of renal risk have been suggested [8–12]. It is suggested that an altered body compo-sition that persists into adulthood could be a risk factor for developing metabolic and cardiovascular diseases, although it could not always be identified as a causal factor [3,5,9, 13,14]. However, the ideal growth pattern for ELBW infants is not yet known.

In addition, analyzing body composition could be useful for calculating drug doses and body composition parameters are used in some prediction models to determine maintenance doses [15].

Literature reviews regarding body composition after hospi-tal discharge and later in life are scarce and most do not dif-ferentiate between gestational age (GA) or birth weight (BW), although they might be important predictors of body compo-sition [16].

This systematic search focuses specifically on ELBW in-fants and investigates their growth patterns and body compo-sition after hospital discharge throughout infancy and adult-hood. Using a systematic review approach, we compared height, weight, HC, and body mass index (BMI) to control data of NBW peers and growth charts described by the World Health Organization (WHO) and the Canadian Pediatric Endocrine Group (CPEG). Parameters regarding body fat and fat distribution were compared to control data in the in-cluded studies.

Materials and methods

Study characteristics

Study design

We performed a systematic search and review including both prospective and retrospective longitudinal studies, as well as cross-sectional studies that describe data in cohorts of former ELBW neonates after hospital discharge until adulthood. There was no limit on minimum or maximum follow-up time. We only included observational studies. Intervention studies were excluded.

Language restrictions

Besides studies and abstracts that were available in English, studies written in a different language were included if they had an abstract or schematics available in English that contained the desired data.

Patients

We included studies concerning former ELBW infants. ELBW is defined as a BW less than 1000 g. ELBW infants are either SGA or appropriate for their GA (AGA). SGA is defined as a BW less than the 10th percentile for weight given the GA [17–22], but studies are heterogeneous as they some-times use different terms and definitions to indicate SGA. Intra-uterine growth restriction is also used as an analogous definition.

(3)

For control data, we simultaneously collected the data of control NBW (i.e., 2500–4000 g) infants matched by sex and age in the concerned study whenever available, and we com-pared the growth parameters to the WHO and CPEG growth charts [23–25].

Search strategy and selection process

A first search was performed by the first author in July 2018 and a second one in December 2018. Databases PubMed, Cochrane Library, Web of Science, and Embase were searched.

The extended search strategies for different databases and selection of the articles are represented in Table1and Fig.1, respectively [26]. The quality of the English studies was assessed using the “Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies” of the National Heart, Lung and Blood Institute [27]. Studies were selected based on title and abstract, and the second author was consulted in case of uncertainties.

Outcome parameters and methodology applied

Parameters that were a component of growth or body compo-sition were extracted by the first author. In case of uncer-tainties, the second author was consulted. Extracted growth parameters are height, weight, HC, and BMI. Parameters re-garding body composition were either absolute (i.e., FM, LM, and total body water (TBW)) or relative (%TBF, percentage lean mass (%LM), and percentage total body water (%TBW)). We also investigated fat distribution.

Growth

We compared mean height, weight, HC, and BMI with data of NBW control children when available in the studies and with the 5th, 25th, and 50th percentile of the standard growth pa-rameters as described in the WHO Child Growth Standards and in the WHO Reference 2007 [23–25]. For weight-for-age after the age of 10, we compared with extended WHO refer-ence curves provided by the CPEG. Since these charts do not provide data for the 5th percentile, we compared to the 3th percentile instead [28].

We plotted the calculated weighted mean data of boys and girls against the WHO growth charts. The WHO data were calculated as the weighted mean of boys and girls equal to the ratio of male to female patients in the concerned studies at the compared age. We plotted growth data in graphs edited in MATLAB, while using a rational function based on the en-tered data [29]. Individual function characteristics of the graphs are described below the figures. The WHO growth charts are used to describe trends among the growth of

ELBW infants, but they were not statistically compared with the study data.

Different definitions of catch-up growth are used in the included studies. Catch-up growth is defined as a positive increase of the Z-score of >0.67 over a certain period of time [20, 30] or reaching growth parameters more than −2 SD scores for age [22,31].

Body composition

For FM, LM, %TBF, and %LM, we compared mean data of ELBW infants to control data as described in the included studies.

Methods to measure growth parameters and body composition

Studies were not excluded based on methods used for mea-suring growth parameters or body composition, as some of these methods are suggested to be more accurate but also more expensive or less applicable to newborn infants [14]. The use of these methodologies is further explained in the studies.

Results

There were 486 search results in PubMed, 33 trials in Cochrane Library, 383 in Embase, and 192 in Web of Science. Two studies that met the selection criteria were ex-cluded to avoid duplication (the study populations were also included in another more comprehensive included study) [32, 33]. Eventually, a total of 16 studies and one abstract were included. The selection process of the articles is represented in the PRISMA flow chart in Fig. 1 [26]. An overview of the included studies and the quality assessment are represented in Table2and Table3, respectively. One study had a very low follow-up rate with a small remaining study sample and was therefore not used for the WHO comparison [38]. Results of growth compared to controls are represented in Table4and those of body composition data in Table5.

Growth

Height

In almost every included study that compared ELBW infants to NBW infants, children and adults born with an ELBW remain smaller than NBW children, at every stage of their development [17–21,30,35–37,39–41]. Two studies found a difference between genders with a lower height in male infants at the age of 11 [41] and in female infants at the age of 14.7 [20]. Two studies suggested that ELBW infants attain

(4)

Table 1 Search strategies for different databases

Database Search strategy

Pubmed (("Extremely Low Birth Weight Infant"[Mesh] OR“Extremely low birth weight infant*”[tiab] OR “ELBW”[tiab] OR “Extremely Low Birth

Weight”[tiab])) AND (“Body Constitution"[Mesh/NoExp] OR “Body Constitution*"[tiab] OR “Body Distribution”[tiab] OR “Body weights and

measures”[Mesh/NoExp] OR “body weights and measures”[tiab] OR “Body Measure*”[tiab] OR “morphometry”[tiab] OR “Morphometrics”[tiab] OR

“Body Fat Distribution”[Mesh] OR “Body Fat Distribution”[tiab] OR “Body Fat Patterning”[tiab] OR “Adiposity”[tiab] OR “Adipose tissue

distribution”[tiab] OR “Fat tissue distribution”[tiab] OR “Fatty Tissue Distribution”[tiab] OR “Body Mass Index”[Mesh] OR “Body Mass Index”[tiab]

OR“Quetelet* Index”[tiab] OR “BMI”[tiab] OR “Body Size”[Mesh/NoExp] OR “Body Size*”[tiab] OR “Body Mass”[tiab] OR “Body

Height”[Mesh/NoExp] OR “Body Height*”[tiab] OR “Body length”[tiab] OR“Body Weight”[Mesh/NoExp] OR “Body Weight*”[tiab] OR “Total

Body Weight”[tiab] OR “Body Weight Changes”[Mesh/NoExp] OR “Body Weight Change*”[tiab] OR “Body Composition”[Mesh] OR “Body

Composition*”[tiab] OR “Body Water”[mesh] OR “body water”[tiab] OR “Whole Body Water”[tiab] OR “Total Water”[tiab] OR “Total Body

Water”[tiab] OR “Total Body Fluid”[tiab] OR “adipose tissue”[Mesh/NoExp] OR “Adipose Tissue*”[tiab] OR “Fat Tissue”[tiab] OR “Fatty

Tissue”[tiab] OR “Fat Pad*”[tiab] OR “Body Fat”[tiab] OR “body lipid”[tiab] OR “visceral fat distribution”[tiab] OR “Subcutaneous Fat

distribution”[tiab] OR “Anthropometry”[Mesh/NoExp] OR “Anthropometry”[tiab] OR “Anthropometric index”[tiab] OR “Anthropometrics”[tiab] OR

“Anthropometric parameters”[tiab] OR “Cephalometry”[mesh] OR “Cephalometry”[tiab] OR “Cephalometrics”[tiab] OR “Craniometry”[tiab] OR “Craniometrics”[tiab] OR “Head circumference”[tiab] OR “Cranial Circumference”[tiab] OR “Fat Mass”[tiab] OR “Fat Free Mass”[tiab] OR “Lean

Mass”[tiab] OR (“Postdischarge”[tiab] or “Postdischarge”[ tiab] AND (“growth”[mesh] OR “growth”[tiab])))

Cochrane Library

#1[mh“Extremely Low Birth Weight Infant”]

#2(“Extremely low Birth Weight Infant” or “ELBW” or “Extemely low birth weight”):ti,ab,kw

#3#1 OR #2

#4[mh ^”Body Constitution”] or [mh ^”Body Weights and measures”] or [mh “Body Fat Distribution”] or [mh “Body Mass Index”] or [mh ^”Body Size”]

or [mh ^”Body Height”] or [mh ^”Body Weight”] or [mh ^”Body Weight Changes”] OR [mh “Body Composition”] or [mh “Body Water”] or [mh

^”Adipose tissue”] or [mh ^”Anthropometry”] or [mh “Cephalometry”]

#5(“Body Constitution” or “Body Distribution” or “body weights and measures” or “Body Measure*” or “morphometry” or “Morphometrics” or “Body

Fat Distribution” or “Body Fat Patterning” or “Adiposity” or “Adipose tissue distribution” or “Fat tissue distribution” or “Fatty Tissue Distribution” or

“Body Mass Index” or “Quetelet* Index” or “BMI” or “Body Size*” or “Body Mass” or “Body Height*” or “Body length” or “Body Weight*” or “Total

Body Weight” or “Body Weight Change*” or “Body Composition*” or “body water” or “Whole Body Water” or “Total Water” or “Total Body Water” or

“Total Body Fluid” or “Adipose Tissue*” or “Fat Tissue” or “Fatty Tissue” or “Fat Pad*” or “Body Fat” or “body lipid” or “visceral fat distribution” or “Subcutaneous Fat distribution” or “Anthropometry” or “Anthropometric index” or “Anthropometrics” or “Anthropometric parameters” or “Cephalometry” or “Cephalometrics” or “Craniometry” or “Craniometrics” or “Head circumference” or “Cranial Circumference” or “Fat Mass” or “Fat

Free Mass” or “Lean Mass”):ti,ab,kw

#6(“Postdischarge” or “Post-Discharge”):ti,ab,kw #7[mh ^”Growth”] #8(“Growth”):ti,ab,kw #9#7 OR #8 #10#6 and #9 #11#5 OR #10 #12#4 OR #11 #13#3 AND #12

EMBASE (‘extremely low birth weight’/exp. OR ‘extremely low birth weight’:ti,ab OR ‘elbw’:ti,ab OR ‘extremely low birth weight infant*’:ti,ab) AND (‘body

constitution’/exp. OR ‘body constitution’:ti,ab OR ‘body distribution’:ti,ab OR ‘morphometry’/mj OR ‘morphometry’:ti,ab OR ‘morphometrics’:ti,ab

OR‘body weights and measures’:ti,ab OR ‘body measure*’:ti,ab OR ‘body composition’/exp. OR ‘body composition’:ti,ab OR ‘body fat’:ti,ab OR

‘body lipid’:ti,ab OR ‘fat load’:ti,ab OR ‘body fat distribution’:ti,ab OR ‘body fat patterning’:ti,ab OR ‘adipose tissue distribution’:ti,ab OR ‘fat tissue

distribution’:ti,ab OR ‘fatty tissue distribution’:ti,ab OR ‘subcutaneous fat distribution’:ti,ab OR ‘visceral fat distribution’:ti,ab OR ‘body water’:ti,ab

OR‘total water’:ti,ab OR ‘whole body water’:ti,ab OR ‘total body water’:ti,ab OR ‘total body fluid’:ti,ab OR ‘adipose tissue’/mj OR ‘adipose

tissue’:ti,ab OR ‘fat tissue’:ti,ab OR ‘fatty tissue’:ti,ab OR ‘fat pad’/exp. OR ‘fat pad*’:ti,ab OR ‘anthropometry’/mj OR ‘anthropometry’:ti,ab OR

‘anthropometric index’:ti,ab OR ‘anthropometrics’:ti,ab OR ‘antropometry’:ti,ab OR ‘body measurement’:ti,ab OR ‘cephalometry’/mj OR ‘cephalometry’:ti,ab OR ‘cephalometrics’:ti,ab OR ‘head size’:ti,ab OR ‘craniometry’/mj OR ‘craniometry’:ti,ab OR ‘craniometrics’:ti,ab OR ‘anthropometric parameters’/mj OR ‘anthropometric parameters’:ti,ab OR ‘body height’/exp. OR ‘body height’:ti,ab OR ‘body length’:ti,ab OR ‘body

weight’/mj OR ‘body weight’:ti,ab OR ‘total body weight’:ti,ab OR ‘body weight change*’:ti,ab OR ‘body mass’/exp. OR ‘body mass’:ti,ab OR

‘bmi’:ti,ab OR ‘body mass index’:ti,ab OR ‘quetelet* index’:ti,ab OR ‘body size’/exp. OR ‘body size’:ti,ab OR ‘fat free mass’/exp. OR ‘fat free

mass’:ti,ab OR ‘fat mass’/exp. OR ‘fat mass’:ti,ab OR ‘lean mass’:ti,ab OR ‘head circumference’/exp. OR ‘head circumference’:ti,ab OR ‘cranial

circumference’:ti,ab OR ((‘postdischarge’:ti,ab OR ‘post-discharge’:ti,ab) AND (‘growth’/mj OR ‘growth’:ti,ab)))

Web of Science TS = ((“Extremely low birth weight infant*” OR “ELBW” OR “Extremely Low Birth Weight”) AND (“Body Constitution*” OR “Body Distribution” OR

“body weights and measures” OR “Body Measure*” OR “morphometry” OR “Morphometrics” OR “Body Fat Distribution” OR “Body Fat Patterning”

OR“Adiposity” OR “Adipose tissue distribution” OR “Fat tissue distribution” OR “Fatty Tissue Distribution” OR “Body Mass Index” OR “Quetelet*

Index” OR “BMI” OR “Body Size*” OR “Body Mass” OR “Body Height*” OR “Body length” OR “Body Weight*” OR “Total Body Weight” OR

“Body Weight Change*” OR “Body Composition*” OR “body water” OR “Whole Body Water” OR “Total Water” OR “Total Body Water” OR “Total

Body Fluid” OR “Adipose Tissue*” OR “Fat Tissue” OR “Fatty Tissue” OR “Fat Pad*” OR “Body Fat” OR “body lipid” OR “visceral fat distribution”

OR“Subcutaneous Fat distribution” OR “Anthropometry” OR “Anthropometric index” OR “Anthropometrics” OR “Anthropometric parameters” OR

“Cephalometry” OR “Cephalometrics” OR “Craniometry” OR “Craniometrics” OR “Head circumference” OR “Cranial Circumference” OR “Fat

Mass” OR “Fat Free Mass” OR “Lean Mass” OR ((“Postdischarge” OR “Post-discharge”) AND “growth”)))

ELBW Extremely low birth weight, BMI Body mass index, Ti title, Ab abstract, Mh MeSH, NoExp unexploded, Tiab title or abstract, Mj major focus, Exp explode, TS top

(5)

a normal height compared with the mean biparental predicted height at 14, 15, and 20 years [36,38].

When compared with the WHO growth charts, ELBW infants seem to have a growth pattern almost similar to the 25th percentile with some values around the 5th percentile under the age of 1. Only a few stud-ies found a height that was comparable with the 50th percentile (Fig. 2).

Weight

Most studies agree that ELBW infants also remain ligh-ter than NBW infants at each corrected age (CA) [17–21, 30, 37, 39–41]. However, two studies did not find a statistical significance between former ELBW and

NBW infants at the age of 14, 20 [36], and 34 [35]. One study described a lower weight in male patients only at the age of 11 [41] and one in female patients only at the age of 14.7 [20].

In their first 7 years of life, ELBW infants seem to have a weight similar to the 25th percentile of the WHO growth charts, with a trend toward the 50th percentile afterwards (Fig.3).

Head circumference

All studies investigating HC report that ELBW infants and adolescents have a smaller HC than NBW control peers in their childhood as well as when they reach adult age [18,19, 30,37,39–41]. g ni n e er c S Included Elig ib ility n oi t ac ifi t n e dI

Records idenfied through database searching (n = 1094) Full-text arcles excluded, with reasons (n = 19) Addional records idenfied

through other sources (n = 2)

Records aer duplicates removed (n = 700) Studies included in qualitave synthesis (n = 17) Records screened (n = 700) Records excluded (n = 664) Full-text arcles assessed for eligibility

(n = 36) Fig. 1 PRISMA 2009 flow

(6)

The WHO growth charts only describe HC until the age of 5. During this period, the HC of ELBW infants seems to fluctuate between the 25th and 50th percentile with a trend toward the 25th percentile (Fig.4).

Body mass index

Since both their height and weight are lower than that of NBW children, it is still unclear whether former ELBW

Table 2 Overview of included studies

Authors and reference

Study design Group N

(male/female)

Age (N) at assessment Mean GA

(weeks)

Mean BW (grams) Measuring

methods Atkinson SA et al.

[34]

Longitudinal cohort

ELBW 125 23.1 ± 1.4y (96) 7.1 ± 2.3 841 ± 125 DEXA

NBW 119 23.5 ± 1.2y (92) NA NA

Crane JD et al. [35] Cross-sectional cohort

ELBW 29 (12/17) 34.3 ± 0.33y NA 830 ± 20 Harpenden

stadiometer Electronic scale MRI; DEXA NBW 16 (7/9) 34.9 ± 0.32y NA 3330 ± 100 Doyle LW et al. [36] Longitudinal cohort

ELBW 42 (15/27) Birth to 20.3 ± 1.0y

at 2y, 5y, 8y, 14y

27.4 ± 2.0 877 ± 86 Harpenden

stadiometer Digital scale

Hack. et al. [20] Longitudinal

cohort

ELBW 148 (52/96) 8y (147); 14y (148) 26.5 ± 2 825 ± 119/813 ± 124 Infantometer;

stadiometer

NBW 176 (65/111) 8y (176); 14y (115) ≥37 3323 ± 597/3238 ± 411

Hill AS et al. [37] Retrospective

cohort

ELBW 46 Birth; discharge; 6 m;

12 m;1 8 m

27.03 ± 1.75 796.22 ± 140.18 NA

Hirata T et al. [38] Longitudinal

cohort

ELBW 103 Follow-up from birth to

14.3 ± 1.8

(8)y / 15.6 ± 1.5y (15)

26.6 ± 1.4 818 ± 110 Standard balance

beam weight scale with height rod

Jordan IM et al. [31]

Retrospective cohort

ELBW 159 (82/77) Birth, TCA, 3 m, 9 m, 18 m,

36 m

28 ± 2 851.2 ± 116.5 NA

Kwinta P et al. [39] Cross-sectional cohort

ELBW 81 (29/52) 6.7 ± 0.4y 27.2 ± 2.1 845 ± 130 Multifrequency

bioimpedance

NBW 39 (19/20) 6.9 ± 0.8y 39.9 ± 1.4 3554 ± 512

Lin YC et al. [40] Retrospective

cohort

ELBW 100 (41/59) 6 m (68), 12 m (67), 24 m (62) 26* 772* Standard procedure

Mól N et al. [41] Prospective

cohort

ELBW 81 (29/52) 6.61 ± 0.36y (81); 11.06 ± 0.38y

(62) 27.3 ± 2.3 843.3 ± 132.4 Standard medical tape; fixed stadiometer Medical scale (nearest 100 g) NBW 36 (19/17) 6.98 ± 0.83y; 10.62 ± 0.82y 39.8 ± 1.4 3589.4 ± 538.8 Monset-Couchard M et al. [22] Longitudinal cohort

ELBW 166 (64/102) Consistent follow-up from birth

to 18 years of age NA NA NA Morrison M et al. [17] Prospective cohort

ELBW 100 (40/60) 31.63 ± 1.66y 27.10 ± 2.45 829.00 ± 130.38 Harpenden

stadiometer Electronic scale DEXA NBW 89 (37/52) 31.96 ± 1.42y NA 3391.30 ± 442.28 Peralta-Carcelen M et al. [18] Cross-sectional cohort

ELBW 53 (22/31) 14.8 ± 1.8y 28.2 ± 2.3 849 ± 109 DEXA

NBW 53 14.9 ± 1.7y >37 3355 ± 526 Raaijmakers A et al. [30] Longitudinal case-control ELBW 93 (49/44) Birth (140); 9 m (118); 24 m (96); 11.3 ± 1.4y (93) NA NA Bioelectrical impedance NBW 87 (43/44) 10.9 ± 1.3y NA NA Rodríguez-Soriano J et al. [21] Longitudinal cohort

ELBW 40 (23/17) 8.6 ± 1.8y 27.6* 845* Harpenden

stadiometer

NBW 43 (25/18) 8.5 ± 1.8y NA NA

Saigal S et al. [19] Prospective

cohort

ELBW 147 (65/82) Birth (179); 1y (157); 2y (137);

3y (123); 8y (147); 14.1 ± 1.6y (144); 23.3 ± 1.2y (147)

27.1 ± 2.3 841 ± 125 Calibrated scale

Balance beam scale

NBW 131 (59/72) 8y (145); 141.4 ± 1.3 (121);

23.6 ± 1.1y (131)

NA 3380 ± 475

Sices L et al. [42] Retrospective

cohort ELBW 154 (71/83) Birth (154); 39.2 ± 3.0w (154); 4.4 ± 0.7 m (143); 8.6 ± 1.0 m (138); 19.0 ± 1.2 m (151) 25.9 ± 1.8 768 ± 140 Harpenden infantemeter Health-o-Meter Scale N is the number of infants in the selected cohort used to determine the mean GA and BW

N at age of assessment was added when different from the initial cohort

ELBW extremely low birth weight, NBW normal birth weight, GA gestational age, w weeks, m months, y years BW birth weight, NA not available; information could not be extracted from the study, DEXA dual-energy x-ray absorptiometry

(7)

Table 3 Quality A ssessment T ool for O bs ervatio na l C ohort and Cross-Se ctional S tudies Cr ite ri a S tudy Cr ane et al . [ 35 ] Doyle etal . [ 36 ] Ha ck. et al . [ 20 ] Hi ll et al . [ 37 ] Hi ra ta et al . [ 38 ] Jordan etal . [ 31 ] Li n et al . [ 40 ] Mól etal . [ 41 ] Mons et-Couch ard et al . [ 22 ] Mor ri son et al . [ 17 ] Pe ra lt a-Ca rc ele n et al . [ 18 ] R aai jmaker s et al . [ 30 ] Rodríguez- So ri an o et al . [ 21 ] Sai g al et al . [ 19 ] Si ce s et al . [ 42 ] 1. W as the res ea rch quast ion o r objective in this p aper clearly stated? Ye s Y es Ye s Y es N o Ye s N o Y es Ye s Y es Ye s Y es Y es Y es Ye s 2. W as the st udy p opulat ion clearly spec if ied and defin ed ? Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Y es Y es Ye s 3. W as the p ar ticip at ion rat e o f eli g ibl e pers ons at least 50%? Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Y es Y es Ye s 4. W ere all the subjects selected or recruit ed from th e sa m e or si milar popu lati ons (in cl udi ng the same time perio d )? W er e in clusi o n and ex cl u si o nf o r b ei n gi nt h e study prespecif ied and appl ied uni form ly to all pat ients ? Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Y es Y es Ye s 5. W as a sample si ze ju sti ficati on, power descri pti on, or var iance and ef fect estimates p rovided? Ye s N o N o N o N o N o N o N o N o N o N o N o N o N o N o 6. For the analys es in thi s paper , were the expos ure(s) of in terest measured prio r to the out come (s ) b ei n g m ea su red? Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Y es Y es Ye s 7. W as the ti mefram e su ff icient so th at one could reason ab ly expect to see an asso ci atio n bet w ee n exp osure and out come if it exis ted? Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Y es Y es Ye s 8. For expos ures that can vary in amount o r le vel, did th e st udy examine d if fere n t levels o f th e expo sure as re la ted to the outcome (e.g.), categories o f expos ure, o r expo sure measured as conti nuous variable)? NA N A N A NA N A NA NA NA NA NA N A N A NA NA N A 9. W ere the expos ure m easures (in d ependent vari ab les clearly d ef ined, valid , reli able, and implemented cons ist en tly across al l st udy p art ici p an ts ? Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Ye s Y es Y es Y es Ye s 10 .W as the exposu re (s ) as sessed more than once over ti m e? NA N A N A NA N A NA NA NA NA NA N A N A NA NA N A 1 1 . W ere the outcom e measures (dependent variables) clearly defin ed , v al id, reli able, and impl em en te d consis tent ly across all stu d y p articipants? Ye s Y es Ye s Y es N o Ye s Y es Ye s Y es Ye s Y es Ye s Y es Y es Y es

(8)

children achieve a BMI score that is equal to that of NBW children and adolescents [17,19,20,36], or if their BMI will be lower [21, 30, 32, 39, 41]. One study found a higher BMI score in ELBW infants, but this result did not reach statistical significance when compared to NBW control subjects [35].

Studies do not contain BMI data under the age of 6.7. By age 8 years and afterwards, BMI scores of former ELBW infants seem to reach values between the 50th and the 75th percentile of the WHO growth charts (Fig.5).

Catch-up growth patterns

Studies investigating catch-up growth commonly report that ELBW infants experience a period of neonatal growth failure from birth to TCA, which sometimes continues until 8 months or even after 1 year of age. This growth failure is followed by a period of catch-up growth, especially for weight and height, which con-tinues until adulthood [19, 20, 22, 35–38, 41, 42].

Studies do not uniformly agree on the time of onset of catch-up growth for different growth parameters and the use of different definitions makes it hard to compare the results. Some found catch-up growth starting from the age of 2 years [19], while others report catch-up growth in most subjects before the age of 3 years [22,31,42].

Former ELBW infants seem to have a marked catch-up growth in weight and height between the age of 8 and 14 years, with a more pronounced increment in weight than in height. During this period, there was also a marked catch-up growth for BMI [19,20,36].

It is suggested that catch-up growth for weight and height in the first 2 years of life or HC in the first 9 months is asso-ciated with a lower %TBF at adolescence. Catch-up growth for weight during childhood (2–11 years) was also associated with a lower %TBF at young adolescence [30]. Hack et al. however discuss that catch-up growth throughout infancy is associated with measures of obesity at the age of 14 and is therefore not beneficial [20].

SGA versus AGA

As the definition is based on a weight, a relevant portion of ELBW infants are SGA, higher than infants born with a NBW [18, 19]. After the age of 8.6 and afterwards, no significant difference in height and weight remained be-tween SGA and AGA infants, but SGA infants reached a height significantly below target height at 11 years [21]. Only one study found a significantly smaller HC in SGA ELBW infants compared to AGA ELBW infants at the age of 14 [18]. Ta bl e 3 (continued ) Cr ite ri a S tudy Cr ane et al . [ 35 ] Doyle etal . [ 36 ] Ha ck. et al . [ 20 ] Hi ll et al . [ 37 ] Hi ra ta et al . [ 38 ] Jordan etal . [ 31 ] Li n et al . [ 40 ] Mól etal . [ 41 ] Mons et-Couch ard et al . [ 22 ] Mor ri son et al . [ 17 ] Pe ra lt a-Ca rc ele n et al . [ 18 ] R aai jmaker s et al . [ 30 ] Rodríguez- So ri an o et al . [ 21 ] Sai g al et al . [ 19 ] Si ce s et al . [ 42 ] 12 . W ere th e out come ass essors bl inded to th e expos ure st atus of parti cipant s? Y es N o N o N o N o N o N o N o N o N o Y es N o No No N o 13 . W as loss to follow-up after basel ine 20% or le ss ? N A Ye s Y es Ye s N o Y es Ye s N o Y es N o Ye s Y es Y es Y es Ye s 14 . W ere k ey pot en tial confou nding v ar iables measured and adjusted st atis tical ly for thei r im p ac t on the rela tion ship b etween expos ure(s) and outcomes? Ye s Y es Ye s N o N o Y es N o N o N o Ye s Y es Ye s N o Y es Ye s CD cannot determine, NA not applicable, NR not reported

(9)

Table 4 : Mean anthropometric p aramet ers ± 1 standard deviation. Age and reference G en Height (cm) W eight (kg) BMI (kg/m 2 )H C (c m ) N ELBW(/NBW) ELBW NB W E LBW N BW ELBW NB W E LBW N B W ELBW NBW 39. 2 w ee ks CA [ 42 ] M /F 4 4 .5 ± 2 .7 NA 2.4 4 ± 0 .4 9 N A N A N A 3 3.2 ± 1 .7 N A 1 54 NA 4m o n th s [ 42 ] M /F 5 9 .3 ± 3 .1 NA 5.6 6 ± 0 .8 9 N A N A N A 4 1.1 ± 1 .5 N A 1 43 NA 6m o n th s [ 40 ] M 65 .2 ± 2 .8 NA 6 .9 ± 1. 1 N A N A N A 4 1 .9 ± 2. 1 N A 2 8 N A F 6 4.1 ± 2.6 N A 6 .5 ± 0 .9 NA NA NA 41.0 ± 1 .6 NA 40 NA 8.6 m ont hs [ 42 ] M /F 6 7 .1 ± 3 .1 NA 7.4 0 ± 1 .0 4 N A N A N A 4 3.9 ± 1 .5 N A 1 38 NA 11 m o n th s [ 19 ]M 70.2 ± 4 .3 N A 7 .7 ± 1 .3 NA NA NA 4 5 .3 ± 1 .8 NA 7 3 -7 4 N A F 6 9.6 ± 4 .4 N A 7 .6 ± 1 .2 NA NA NA 4 4 .2 ± 1 .7 NA 8 0 -8 3 N A 12 m onth s [ 40 ] M 73 .7 ± 4 .0 NA 8 .5 ± 1. 1 N A N A N A 4 4 .5 ± 1. 6 N A 2 6 2 6 F 7 2 .9 ± 2 .6 N A8 .1 ± 1 .1 8 N AN AN A 4 3 .7 ± 1 .8 N A 4 1 N A 19 m onth s [ 42 ] M /F 7 9 .6 ± 3 .5 NA 9.9 8 ± 1 .4 2 N A N A N A 4 6.6 ± 1 .6 N A 1 51 NA 23 m onth s [ 19 ] M 8 2 .9 ± 4 .2 NA 10. 4 ± 1.6 N A N A N A 4 7.8 ± 1 .9 N A 6 4-66 NA F 8 1.8 ± 3 .9 N A 10. 2 ± 1.5 N A N A N A 4 6.9 ± 1 .4 N A 7 0-71 NA 2y ea rs [ 40 ] M 8 5 .1 ± 5 .2 NA 10. 7 ± 1.8 N A N A N A 4 6.5 ± 2 .3 N A 2 8 N A F 8 4.9 ± 3 .2 N A 10. 7 ± 1.5 N A N A N A 4 5.9 ± 1 .8 N A 3 4 N A 34 m onth s [ 19 ] M 9 1 .1 ± 5 .0 NA 12. 2 ± 1.7 N A N A N A 4 9.3 ± 1 .8 N A 5 6-59 NA . F 9 0 .4 ± 4 .6 NA 12. 2 ± 1.7 N A N A N A 4 7.9 ± 1 .5 N A 5 6-64 NA 6.7 /6. 9 y ea rs [ 39 ] M /F 1 1 5.3 ± 7 1 2 4 .5 2 ± 7.3 9 19. 7 ± 4,7 2 5.2 3 ± 5 .3 5 1 4.6 ± 2 .2 1 6 .16 ± 2 .34 4 9.6 ± 2 .2 5 2 .2 ± 1. 33 8 1 3 6 7.8 /ye ar s [ 19 ] M 1 21. 7 ± 7.8 1 2 8 .2 ± 5 .7 22. 5 ± 4.7 2 7.3 ± 5 .0 N A N A 5 1.5 ± 1 .5 5 3 .3 ± 1. 4 6 7 6 6 F 1 20. 9 ± 6.1 1 2 8 .1 ± 5 .7 21. 9 ± 3.4 2 7.8 ± 5 .2 N A N A 5 0.6 ± 1 .4 5 2 .7 ± 1. 5 8 0 7 9 8 /9. 2 y ear s [ 20 ] M 1 26. 6 ± 8.8 1 3 3 .4 ± 8 .0 28. 1 ± 10. 8 3 3.1 ± 1 0 .4 1 7 .1 ± 4 .2 * 18 .3 ± 4 .2 * NA NA 52 42 . F 1 28. 7 ± 8.3 1 3 6 .2 ± 8 .3 29. 3 ± 9.0 3 5.2 ± 1 1 .2 1 7 .4 ± 4 .0 * 18 .6 ± 4 .2 * NA NA 96 73 8.6 /8. 5 y ea rs [ 21 ] M /F 1 2 6 ± 12 13 1 ± 15 26 ± 7 3 4 ± 9 1 6 .0 ± 2 .3 19 .3 ± 2 .7 NA NA 4 0 4 3 11 y ea rs [ 41 ] M /F 1 41. 7 ± 7.8 3 14 6.2 6 ± 8 .8 1 33. 88 ± 8 .315 3 9 .9 ± 9 .3 1 6 .7 4 ± 3.2 6 18 .72 ± 3 .4 5 1.3 7 ± 2 .2 4 5 4 .02 ± 1 .42 6 2 3 6 1 1 .3 y10 .9 ye ar s* * [ 30 ] M /F 1 45. 1 ± 9.3 1 4 9 .2 ± 1 0.1 36. 7 ± 9.6 3 9.9 ± 9 .3 1 7.0 ± 2 .8 1 7 .7 ± 2. 5 5 1.7 ± 1 .8 5 3 .4 ± 1. 6 9 3 8 7 14. 1/1 4 .4 y ea rs [ 19 ] M 1 58. 3 ± 14. 4 1 6 7 .4 ± 1 0.9 48. 7 ± 14. 3 5 9.6 ± 1 4 .7 NA NA 5 4 .3 ± 2 .1 56 .6 ± 1 .6 6 3 -6 5 5 2-53 F 1 54. 2 ± 7.5 1 6 1 .9 ± 6 .8 48. 1 ± 1 1 .7 5 6 .2 ± 1 0.5 N A N A 5 3.6 ± 1 .8 5 5 .6 ± 2. 0 7 8-79 6 8 14. 7/1 4 .8 y ea rs [ 20 ] M 1 64. 0 ± 9.4 * 16 7.1 ± 7 .6 * 58. 5 ± 21. 0 * 63 .0 ± 1 8 .0 * 2 1 .4 ± 6 .1 * 22 .4 ± 5 .5 * NA NA 52 42 F 1 56. 8 ± 6.2 1 6 1 .9 ± 6 .1 56. 6 ± 15. 1 6 3.2 ± 1 9 .3 2 2 .9 ± 5 .6 * 24 .0 ± 6 .8 * NA NA 96 73 14. 8/1 4 .9 y ea rs [ 18 ] M /F 1 60. 5 ± 9.3 1 6 5 .3 ± 8 .2 55. 3 ± 15. 0 6 4.4 ± 1 6 .1 NA NA 5 4 .7 ± 2 .1 56 .0 ± 1 .9 5 3 5 3 14. 3 y ea rs [ 38 ] M 1 72. 0 ± 21. 2 N A 51. 3 ± 10. 9 N A N A 5 5 .1 ± 1. 7 N A 8 NA 15. 6 y ea rs [ 38 ] F 1 59. 7 ± 6.7 N A 56. 6 ± 8.7 N A N A N A 5 4 ± 1.7 N A 1 5 N A 23. 3/2 3 .6 y ea rs [ 19 ] M 1 70. 6 ± 9.5 1 7 7 .8 ± 7 .8 70. 7 ± 14. 9 7 7.2 ± 1 4 .6 2 4 .2 ± 4 .6* 2 4 .4 ± 4. 4 5 6.3 ± 1 .8 5 7 .8 ± 1. 4 6 5 5 9 . F 1 58. 3 ± 6.8 1 6 4 .5 ± 6 .7 60. 1 ± 13. 6 6 7.2 ± 1 6 .0 2 4 .0 ± 5 .6* 2 4 .8 ± 5. 3 5 4.1 ± 1 .6 5 5 .8 ± 2. 0 8 2 7 2 31. 63/ 31. 96 ye ar s [ 17 ] M /F 1 6 4 ± 10 17 1 ± 1 1 71. 90 ± 1 6 .54 7 7 .5 0 ± 18. 28 2 6 .9 1 ± 6.4 1 * 2 6 .49 ± 5 .08 N A N A N A 1 00 34. 3/3 4 .9 y ea rs [ 35 ] M /F 16 4 ± 2 1 71 ± 3 7 3 .8 ± 2 .8 * 72 ± 4 .1 27 .4 ± 1 .0 * 2 4. 5 ± 1 .0 N A N A 2 9 1 6 Height, w eight, B MI and H C are re pr ese n te d for ag e. * p > 0 .05; no significant dif ference between E LBW and NBW in fan ts ** p < 0 .05; dif ference in height, w eig h t and BMI w as st ill si gnif ica nt af te r correcting for age EL B W extremely low birth w eight, NBW normal b irth weight, BMI body mass ind ex, HC head circumference, NA not available; data that could not be extracted from the study ,G en gend er , M male, F fe ma le ,N number o f p articipants in the ELBW or NBW g roup.

(10)

Body composition

FM, LM, and relative body composition

Two studies report a lower %LM or lean mass index (LMI, i.e., total lean mass/height2), with a higher %TBF and fat mass index (FMI, i.e., total fat mass/height2) in ELBW infants [17, 30]. The third study found a higher %TBF in male infants only [34]. Otherwise, a fourth study found a significantly lower absolute LM and FM, but also a lower %TBF in children born with an ELBW at the age of 7 [39].

The fifth study found no significant difference in %TBF and %LM between ELBW and NBW infants reaching the age of 14. They conclude that ELBW infants have a lower FM and LM, but that the relative body composition is similar to those of NBW children [18] (Table5).

There was no difference in body composition between SGA and AGA ELBW infants [18,30].

Fat distribution

Only one study and one abstract reported on fat distribution in ELBW infants with different results since ELBW infants had a higher portion of visceral adipose tissue deposition in one study [34], and this higher portion was limited to the subcu-taneous fat areas only in the other study [35]. The last report also found higher proportions of pancreatic and liver fat in ELBW infants reaching young adulthood, but an ELBW was not an independent influencer of these fat fractions [35]. Body water

Two studies investigated body water in ELBW infants, with contradictory results. One study found lower absolute TBW but a higher %TBW in former ELBW infants [39], while the other found no significant difference in %TBW between ELBW and NBW infants [30].

Discussion

Children born as ELBW infants have a specific growth pattern until birth and exhibit a different body composition at birth and TCA than their NBW counterparts. Their compromised growth may result in a body composition later in life that differs from NBW children. Literature describing growth and evolution of body composition after hospital discharge and in later life, however, is scarce. Therefore, we performed a systematic literature search regarding growth parameters and body composition in former ELBW infants throughout child-hood and adolescence.

Most studies state that ELBW infants remain smaller and lighter than NBW infants at every stage of their

Table 5 Bo dy compos ition: FM, % TBF , LM, % LM ± 1 st andard deviation A g e (year s) and ref ere n ce Gen F at ma ss (kg) %T BF Le an mass (kg ) %L M N ELBW/N BW ELBW NBW E LBW N BW ELBW NBW E LB W N BW ELBW NBW 6.7/6.9 [ 39 ] M/ F 2.4 ± 1.98 4.3 ± 0.76 1 1 .3 ± 7 .5 16.3 ± 8.15 17.3 ± 2.66 20.3 ± 3.64 NA NA 81 39 11 .3 /10.9** [ 30 ] M/ F NA NA 24.6 ± 9.8 19.2 ± 0.1 N A N A 75.1 ± 10.2 80.5 ± 8 .9 9 3 8 7 14.8/14.9 [ 18 ] M/ F 13.09 ± 8 .82 17.20 ± 9 .58 23.09 ± 10.99* 25.99 ± 1 0.74 38. 81 ± 10.19 43.40 ± 9 .72 72.72 ± 10.62* 69.93 ± 10.40 53 53 23.1/25.3 [ 34 ] M NA NA 20.3 ± 6.6 16.6 ± 5.2 N A N A N A N A 4 1 4 0 F NA NA 30.6 ± 7.1* 29.0 ± 6.4 N A N A N A N A 5 5 5 2 31.63/31.96 [ 17 ] M/ F NA NA 35.45 ± 10.81 30.75 ± 1 0.49 NA NA NA NA 100 89 FM, T B F , L M and % L M are represented for age. *P > 0 .0 5 **P < 0 .05: results were still signi ficant after correction for age EL B W extr emely low bir th w ei ght, NBW normal b irth weight, FM fa t m ass, %TBF percentage total bod y fat, LM lea n mass, %LM per cent age le an ma ss, NA not availab le; data that could not be extracted from the study , Ge n gender , M male, F fe ma le

(11)

development. In two studies, ELBW infants attained their predicted biparental target height [36, 38]. Although catch-up growth is often described, ELBW infants still attain lower growth parameters by the time they reach adulthood. Since their growth restriction is expressed both in weight and height, it is not clear whether their BMI at

teen and adult age significantly differs from that of NBW infants or not. It is suggested that catch-up growth is more pronounced for weight than for height (“stunting”), resulting in infants being proportionally heavier for their height, although former ELBW infants are never assumed to have a significantly higher BMI score [20, 32,36]. Fig. 2 Height for age. Height for age is plotted for ELBW infants. The

shaded areas represent the 5th–25th and 25–50th percentiles of the WHO growth charts;ELBW function: General model Rat44: f(x) = (p1*x^4 + p2*x^3 + p3*x^2 + p4*x + p5) /, (x^4 + q1*x^3 + q2*x^2 + q3*x + q4),

Coefficients (with 95% confidence bounds): p1 = 204.5 (−159.7,

568.8), p2 =−2524 (−1.05e+04, 5452), p3 = −2966 (−2.332e+05,

2.272e+05), p4 = 5.533e+05 (−4.751e+06, 5.858e+06), p5 = 1.924e+05 (−1.825e+06, 2.21e+06), q1 = 2.602 (−197.4, 202.6), q2 = −432.9

(−5454, 4588), q3 = 6270 (−5.07e+04, 6.324e+04), q4 = 4312

(−4.087e+04, 4.95e+04), Goodness of fit: SSE: 36.72;R2: 0.999;

Adjusted R2: 0.9984; RMSE: 1.62; SSE sum of squared estimate of errors,

RMSE root mean square error

Fig. 3 Weight for age. Weight for age is plotted for ELBW infants. The

shaded areas represent the 5th–25th and 25th–50th percentiles of the

WHO/CPEG growth charts and the 3th–25th percentiles of the extended

charts provided by the CPEG;ELBW function: General model Rat45:

f(x) = (p1*x^4 + p2*x^3 + p3*x^2 + p4*x + p5) /; (x^5 + q1*x^4 + q2*x^3 + q3*x^2 + q4*x + q5); where x is normalized by mean 9.043 and std. 10.21; Coefficients (with 95% confidence bounds): p1 =

5.146e+06 (−3.084e+11, 3.084e+11); p2 = 9.356e+06 (−5.607e+11,

5.607e+11); p3 = 4.198e+06 (−2.516e+11, 2.516e+11); p4 = 9.184e+05

(−5.504e+10, 5.505e+10); p5 = 8.684e+05 (−5.204e+10, 5.204e+10);

q1 = 4.386e+04 (−2.628e+09, 2.628e+09); q2 = 1.847e+05 (−1.107e+

10, 1.107e+10); q3 = 7.957e+04 (−4.768e+09, 4.768e+09); q4 =

−1.152e+04 (-6.898e+08, 6.898e+08); q5 = 3.429e+04 (−2.055e+09,

2.055e+09); Goodness of fit: SSE: 32.65; R2: 0.9972; Adjusted R2:

0.9949; RMSE: 1.723; SSE sum of squared estimate of errors, RMSE root mean square error

(12)

Former ELBW infants do not only reach a lower target height and weight at every CA but they also have a smaller HC. It has been suggested that a smaller HC is related to poorer cognitive outcomes [43–45], but one study investigat-ing neurodevelopment did not find an association between catch-up growth for HC and neurocognitive outcome [30].

When comparing with the WHO growth charts, we came to similar results, especially for height and HC. ELBW infants

seem to attain a height around the 25th percentile at young adult age. Their HC also seems to be around the 25th percen-tile. In the first 7 years of life, their weight and BMI remain around the 25th percentile with afterwards a trend toward the 50th percentile. Their BMI seems to reach values between the 50th and the 75th percentile by young adulthood.

In the studies that linked catch-up growth to adverse health outcomes, there is no consensus whether early catch-up growth is Fig. 4 Head circumference for age. Head circumference for age is plotted

for ELBW infants. The shaded areas represent the 5th–25th and 25–50th

percentiles of the WHO growth charts;ELBW function: General model

Rat24: f(x) = (p1*x^2 + p2*x + p3) / ; (x^4 + q1*x^3 + q2*x^2 + q3*x +

q4); Coefficients (with 95% confidence bounds): p1 =−4439 (−3.263e+

05, 3.174e+05); p2 = 1.478e+06 (−4.638e+06, 7.593e+06); p3 = 4.502e+

05 (−1.222e+06, 2.123e+06); q1 = 32.91 (−70.88, 5.063); q2 = 27.98

(−7218, 7274); q3 = 2.934e+04 (−9.444e+04, 1.531e+05); q4 = 1.349e+

04 (−3.662e+04, 6.359e+04); Goodness of fit: SSE: 5.773; R2

: 0.99;

Adjusted R2: 0.9845; RMSE: 0.7244; SSE sum of squared estimate of

errors, RMSE root mean square error

Fig 5 BMI for age. BMI for age is plotted for ELBW infants. The shaded

areas represent the 25th–50th, 50–75th, and 75th–95th percentiles of the

WHO growth charts;ELBW function: General model Rat34: f(x) = (

p1*x^3 + p2*x^2 + p3*x + p4) /; (x^4 + q1*x^3 + q2*x^2 + q3*x + q4);

Coefficients (with 95% confidence bounds): p1 = 2361 (−1.199e+06,

1.203e+06); p2 = 87.87 (−4.044e+11, 4.044e+11); p3 = 857.6

(−1.361e+11, 1.361e+11); p4 = 225.7 (−1.909e+11, 1.909e+11); q1 =

7.852 (−1.713e+08, 1.713e+08); q2 = 1665 (−1.279e+09, 1.279e+09);

q3 =−4398 (−2.848e+11, 2.848e+11); q4 = −1901 (−8.607e+11,

8.607e+11); Goodness of fit: SSE: 9.316; R2: 0.9557; Adjusted R2:

0.8008; RMSE: 2.158; SSE sum of squared estimate of errors, RMSE root mean square error

(13)

beneficial for metabolic and cardiovascular diseases, hyperten-sion, and renal function later in life or not [12,19,20,30].

With regard to body composition and fat distribution in ELBW infants, there remains some controversy. Studies do not agree on differences in %LM, FM, %TBF and fat distri-bution [17,18,30,34,35,39].

It is suggested that an aberrant body composition with a higher %TBF could indeed make ELBW infants and adoles-cents more susceptible to cardiovascular diseases and insulin resistance [17,30,34].

Nevertheless, there is a lack in information about the body composition in former ELBW infants and it is possible that differences in body composition and fat distribution only ap-pear with advancing age, thus there is a need for longitudinal studies [17]. There is also no agreement on the ideal measure method to investigate body composition.

There are some limitations to this review as a result of the inclusion of long-term follow-up studies and the comparison of cases at different points of time.

Some of the study patients were born in the 1990s or ear-lier. Perinatal care and nutritional practices have since evolved, so one should be careful extrapolating these results to the current population of ELBW neonates [17,18].

Another consequence of including longitudinal follow-up studies is a certain degree of loss of follow-up for part of the subjects, which could cause bias in the remaining study population.

Furthermore, because we did not have access to individual growth data in the different studies, we focused on mean data. Studies also use different definitions of SGA and often do not compare the GA of SGA and AGA infants. This is an import limitation, as SGA infants will have a higher GA per definition and might therefore exhibit a different growth pattern. Nevertheless, the results in most of the studies so far do not show a significant difference in growth parameters between SGA and AGA infants after the age of 8.6, but former SGA infants often represent the smallest spectrum of ELBW infants later in life. One more main limitation is the assessment at many different time points and the heterogeneity of the study populations.

Future studies should investigate the correlation between growth, weight gain, and adipose tissue development since not only ELBW but also BMI is suggested to be a possible influencer of body composition and related adverse health outcomes [17].

Intervention studies should focus on proportional growth and weight gain, especially from the age of 8 until the age of 14. However, increase in height and weight during this period might be influenced by inadequate growth in the first years of life. Also, catch-up growth for height and weight in the first 2 years of life might be beneficial for body composition later in life [19,20,30,36,41]. Careful follow-up throughout child-hood is therefore needed to optimize the growth patterns of ELBW infants.

Conclusion

Studies consistently report that ELBW infants attain lower growth parameters than NBW control patients after hospital discharge throughout childhood and adolescence. Although there seems to be a certain degree of catch-up growth for all growth parameters, differences in anthropometric parameters continue to exist with advancing age. Since catch-up growth is often more pronounced for weight than for height, it is impor-tant to strive for proportional growth in intervention studies.

There is a lack of studies investigating body composition in ELBW infants. There is some evidence that they might have an aberrant body composition, but studies do not draw uni-form conclusions. Associations between body composition and cardiovascular diseases are suggested. Further research and longitudinal studies are needed to ascertain whether the higher prevalence of metabolic and cardiovascular diseases could indeed be a consequence of an aberrant growth pattern, different body composition, or inadequate fat tissue development.

Authors’ Contributions Both authors drafted the study and were involved

in the study design. C.V.d.P. performed the systematic review. In case of uncertainties, the second author was consulted. Both authors wrote the final manuscript and approved the manuscript.

Funding There is no funding source.

Compliance with ethical statements

Ethical approval This article does not contain any studies with human

participants or animals performed by any of the authors.

Conflict of interest The authors declare that they have no conflict of

interest, and there was no specific funding for this project.

References

1. Tremblay G, Boudreau C, Bélanger S, St-Onge O, Pronovost E,

Simonyan D, Marc I (2017) Body composition in very preterm infants: role of neonatal characteristics and nutrition in achieving

growth similar to term infants. Neonatology 111:214–221.https://

doi.org/10.1159/000450882

2. Johnson MJ, Wootton SA, Leaf AA, Jackson AA (2012) Preterm

birth and body composition at term equivalent age: a systematic

review and meta-analysis. Pediatrics 130:e640–e649.https://doi.

org/10.1542/peds.2011-3379

3. Cole TJ, Statnikov Y, Santhakumaran S, Pan H, Modi N (2014)

Birth weight and longitudinal growth in infants born below 32 weeks’ gestation: a UK population study. Arch Dis Child Fetal

Neonatal Ed 99:F34–F40.

https://doi.org/10.1136/archdischild-2012-303536

4. Osmond C, Barker DJ (2000) Fetal, infant, and childhood growth

are predictors of coronary heart disease, diabetes, and hypertension

in adult men and women. Environ Health Perspect 108:545–553.

(14)

5. Euser AM, de Wit CC, Finken MJJ, Rijken M, Wit JM (2008)

Growth of preterm born children. Horm Res Paediatr 70:319–328.

https://doi.org/10.1159/000161862

6. Barker DJP (2006) Adult consequences of fetal growth restriction.

Clin Obstet Gynecol 49:270–283. https://doi.org/10.1097/

00003081-200606000-00009

7. Euser AM (2009) Long-term consequences of differences in early

growth: epidemiological aspects. Retrieved from https://

openaccess.leidenuniv.nl/handle/1887/14485. Accessed 10

Dec 2019

8. Luyckx VA, Perico N, Somaschini M, Manfellotto D, Velensise H,

Cetin I, Simeoni U, Allegaert K, Vikse BE, Steegers EA, Adu D, Montini G, Remuzzi G, Brenner BM, writing group of the Low Birth Weight and Nephron Number Working Group (2017) A de-velopmental approach to the prevention of hypertension and kidney disease: a report from the low birth weight and nephron number

working group. Lancet 390:424–428.https://doi.org/10.1016/

S0140-6736(17)30576-7

9. Ong KK, Kennedy K, Castañeda-Gutiérrez E, Forsyth S, Godfrey

KM, Koletzko B, Latulippe ME, Ozanne SE, Rueda R, Schoemaker MH, van der Beek EM, van Buuren S, Fewtrell M (2015) Postnatal growth in preterm infants and later health

out-comes: a systematic review. Acta Paediatr 104:974–986.https://

doi.org/10.1111/apa.13128

10. Barker DJ, Osmond C, Winter PD, Margetts B, Simmonds SJ

(1989) Weight in infancy and death from ischaemic heart disease.

Lancet 334:577–580. https://doi.org/10.1016/S0140-6736(89)

90710-1

11. Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB (2000)

Association between postnatal catch-up growth and obesity in childhood: prospective cohort study [corrected] [published erratum appears in BR MED J 2000; 320(7244): 1244]. BMJ Br Med J

(International Ed) 320:967–971.https://doi.org/10.1136/bmj.320.

7240.967

12. Fewtrell MS, Doherty C, Cole TJ, Stafford M, Hales CN, Lucas A

(2000) Effects of size at birth, gestational age and early growth in

preterm infants on glucose and insulin concentrations at 9–12 years.

Diabetologia 43:714–717.https://doi.org/10.1007/s001250051368

13. Parkinson JRC, Hyde MJ, Gale C, Santhakumaran S, Modi N

(2013) Preterm birth and the metabolic syndrome in adult life: a

systematic review and meta-analysis. Pediatrics 131:e1240–e1263.

https://doi.org/10.1542/peds.2012-2177

14. Strydom K, Van Niekerk E, Dhansay MA (2019) Factors affecting

body composition in preterm infants: assessment techniques and

nutritional interventions. Pediatr Neonatol 60:121–128.https://doi.

org/10.1016/j.pedneo.2017.10.007

15. Holford N (2010) Dosing in children. Clin Pharmacol Ther 87:367–

370.https://doi.org/10.1038/clpt.2009.262

16. Ahmad I, Nemet D, Eliakim A, Koeppel R, Grochow D, Coussens

M, Gallitto S, Rich J, Pontello A, Leu S, Cooper DM, Waffarn F (2010) Body composition and its components in preterm and term newborns: a cross-sectional, multimodal investigation. Am J Hum

Biol 22:69–75.https://doi.org/10.1002/ajhb.20955

17. Morrison KM, Ramsingh L, Gunn E, Streiner D, Van Lieshout R,

Boyle M, Gerstein H, Schmidt L, Saigal S (2016) Cardiometabolic health in adults born premature with extremely low birth weight.

Pediatrics 138:e20160515.https://doi.org/10.1542/peds.2016-0515

18. Peralta-Carcelen M, Jackson DS, Goran MI, Royal SA, Mayo MS,

Nelson KG (2000) Growth of adolescents who were born at ex-tremely low birth weight without major disability. J Pediatr 136:

633–640.https://doi.org/10.1067/mpd.2000.104291

19. Saigal S, Stoskopf B, Streiner D, Paneth N, Pinelli J, Boyle M

(2006) Growth trajectories of extremely low birth weight infants from birth to young adulthood: a longitudinal, population-based

study. Pediatr Res 60:751–758.https://doi.org/10.1203/01.pdr.

0000246201.93662.8e

20. Hack M, Schluchter M, Margevicius S, Andreias L, Taylor HG,

Cuttler L (2014) Trajectory and correlates of growth of

extremely-low-birth-weight adolescents. Pediatr Res 75:358–366.https://doi.

org/10.1038/pr.2013.209

21. Rodriguez-Soriano J, Aguirre M, Oliveros R, Vallo A (2005)

Long-term renal follow-up of extremely low birth weight infants. Pediatr

Nephrol 20:579–584.https://doi.org/10.1007/s00467-005-1828-6

22. Monset-Couchard M, de Bethmann O (2000) Catch-up growth in

166 small-for- gestational age premature infants weighing less than

1,000 g at birth. Neonatology 78:161–167.https://doi.org/10.1159/

000014265

23. Group WMGRS (2006) WHO child growth standards: length/

height-for-age, age, length, weight-for-height and body mass index-for-age: methods and development.

Geneva World Heal Organization 1–312

24. WHO (2007) WHO child growth standards: head

circumference-for-age, arm circumference-circumference-for-age, triceps skinfold-for-age and subscapular skinfold-for-age: methods and development. Geneva World Heal Organization

25. de Onis M (2007) Development of a WHO growth reference for

school-aged children and adolescents. Bull World Health Organ 85:

660–667.https://doi.org/10.2471/BLT.07.043497

26. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred

reporting items for systematic reviews and meta-analyses: the

PRISMA statement. PLoS Med 6:e1000097. https://doi.org/10.

1371/journal.pmed.1000097

27. Quality Assessment Tool for Observational Cohort and

Cross-Sectional Studies. Retrieved from: https://www.nhlbi.nih.gov/

health-topics/study-quality-assessment-tools. Accessed 10

Dec 2019

28. Rodd C, Metzger DL, Sharma A, Cummings E, Chanoine JP,

Lawrence S, Palmert M (2014) Extending World Health Organization weight-for-age reference curves to older children.

BMC Pediatr 14:1–7.https://doi.org/10.1186/1471-2431-14-32

29. Matlab (1994) The Mathworks, Inc.

30. Raaijmakers A, Jacobs L, Rayyan M, van Tienoven TP, Ortibus E,

Levtchenko E, Staessen JA, Allegaert K (2017) Catch-up growth in the first two years of life in extremely low birth weight (ELBW) infants is associated with lower body fat in young adolescence.

PLoS One 12:e0173349.https://doi.org/10.1371/journal.pone.

0173349

31. Jordan IM, Robert A, Francart J, Sann L, Putet G (2005) Growth in

extremely low birth weight infants up to three years. Neonatology

88:57–65.https://doi.org/10.1159/000084701

32. Saigal S, Stoskopf BL, Streiner DL, Burrows E (2001) Physical

growth and current health status of infants who were of extremely

low birth weight and controls at adolescence. Pediatrics 108:407–

415.https://doi.org/10.1542/peds.108.2.407

33. Starzec K, Klimek M, Grudzień A, Jagla M, Kwinta P (2016)

Longitudinal assessment of renal size and function in extremely low birth weight children at 7 and 11 years of age. Pediatr

Nephrol 31:2119–2126.

https://doi.org/10.1007/s00467-016-3413-6

34. Atkinson SA, Steele S, Stoskoff B, Saigal S (2005) Program

ab-stracts. Pediatr Res 58:1008–1139. https://doi.org/10.1203/

00006450-200511000-00033

35. Crane JD, Yellin SA, Ong FJ, Singh NP, Konyer N, Noseworthy

MD, Schmidt LA, Saigal S, Morrison KM (2016) ELBW survivors in early adulthood have higher hepatic, pancreatic and

subcutane-ous fat. Sci Rep 6:31560.https://doi.org/10.1038/srep31560

36. Doyle LW (2004) Extremely low birth weight and body size in

early adulthood. Arch Dis Child 89:347–350.https://doi.org/10.

1136/adc.2002.025924

37. Hill AS, Nguyen H, Dickerson KL (2009) Catch-up growth for the

extremely low birth weight infant. Pediatr Nurs 35:181–188

(15)

38. Hirata T, Bosque E (1998) When they grow up: the growth of

extremely low birth weight (≤1000 gm) infants at adolescence. J

Pediatr 132:1033–1035.https://doi.org/10.1016/S0022-3476(98)

70404-4

39. Kwinta P, Klimek M, Grudzień A, Piatkowska E, Kralisz A,

Nitecka M, Profus K, Gasińska M, Pawlik D, Lauterbach R,

Olechowski W, Drożdż D, Pietrzyk JJ (2012) Assessment of

somat-ic development and body composition in the 7th year of life in

children born as extremely low birth weight infants (≤1000g); a

multi-centre cross-sectional study of a cohort born between 2002 and 2004 in the Malopolska voivodship. Med Wieku Rozwoj 16:

81–88 Retrieved fromhttp://www.medwiekurozwoj.pl. Accessed

10 Dec 2019

40. Lin Y-C, Lin Y-J, Lin C-H (2011) Growth and neurodevelopmental

outcomes of extremely low birth weight infants: a single center’s

experience. Pediatr Neonatol 52:342–348.https://doi.org/10.1016/

j.pedneo.2011.08.008

41. Mól N, Zasada M, Klimek M, Kwinta P (2017) Somatic

develop-ment and some indices of lipid metabolism in 11-year-old children born with extremely low birth weight (≤1000 g) (long-term cohort

study). Dev Period Med 21:361–368 Retrieved fromhttp://www.

medwiekurozwoj.pl. Accessed 10 Dec 2019

42. Sices L, Wilson-Costello D, Minich N, Friedman H, Hack M

(2007) Postdischarge growth failure among extremely low birth weight infants: correlates and consequences. Paediatr Child

Health (Oxford) 12:22–28.https://doi.org/10.1093/pch/12.1.22

43. Powls A, Botting N, Cooke RWI, Pilling D, Marlow N (1996)

Growth impairment in very low birthweight children at 12 years: correlation with perinatal and outcome variables. Arch Dis Child

Fetal Neonatal Ed 75:F152–F157.https://doi.org/10.1136/fn.75.3.

F152

44. Cooke RWI (2003) Growth impairment in the very preterm and

cognitive and motor performance at 7 years. Arch Dis Child 88:

482–487.https://doi.org/10.1136/adc.88.6.482

45. Stathis SL, O’Callaghan M, Harvey J, Rogers Y (1999) Head

cir-cumference in ELBW babies is associated with learning difficulties and cognition but not ADHD in the school-aged child. Dev Med

Child Neurol 41:S0012162299000833.https://doi.org/10.1017/

S0012162299000833

Publisher’s note Springer Nature remains neutral with regard to

Referenties

GERELATEERDE DOCUMENTEN

Wanneer de partijen een gezamenlijk probleem ervaren en dit samen willen oplossen kan dit leiden tot co-makership (Hoeve, Smulders, &amp; Van der Meer, 2013). Mogelijk kan de LGW

Experiences of case managers in providing person-centered and integrated care based on the Chronic Care Model: A qualitative study on embrace..

We note that, in case there are multiple undercutters of an evidential support arc, the CPTs for the nodes corresponding to the tails need to be further constrained such that

Due to the restriction of technological developments the following trends occur in the near future: strengthening of the local content market by EU subsidising, new content

biblio, creagroep Participanten: Bewoners Ondernemers/middenstand Hotel Museum Haven Gemeente Groninger Huis Aanpak: Bewonersregie Samenhang Kennis Projectmatig

Based on empirical findings within present study, there can be concluded that the CBRM method performs better in showing the relationship between a consumer and multiple brands in

Het gebruik van het partikel toch zal bij non-profit organisaties zorgen voor een hogere evaluatie van hun webcare vergeleken met het partikel wel of het weglaten van een

Onderzocht is onder welke feiten en omstandigheden het medisch beroepsgeheim volgens het tuchtcollege wel of niet wordt geschonden, wanneer er een melding van kindermishandeling